Let’s start with a health warning about this stock. It falls within the category of so-called “sin” stocks. It makes and markets products that many people dislike intensely. And it goes against the grain of modern medical opinion. We’re not here, though, to make moral judgements about portfolio selections. Our job is to highlight interesting investment opportunities, while leaving
A recovery play with a rich yield
Aug 11, 2023
2 minutes
You’re reading a preview, subscribe to read more.
Start your free 30 days